Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease

Brain Research

Volumn 780, Issue 2, 1998, Pages 294-303

  Hauss Wegrzyniak, Beatrice ^a   Dobrzanski, Pawel ^b   Stoehr, James D ^c   Wenk, Gary L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b Cephalon   (United States)

^c MIDWESTERN UNIVERSITY   (United States)

Author keywords

Acetylcholine; Alzheimer's disease; Basal forebrain; Model; Neuroinflammation; Rat

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN FOURTH VENTRICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MICROGLIA; NEUROBIOLOGY; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SPATIAL MEMORY; TEMPORAL LOBE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; CHOLINE O-ACETYLTRANSFERASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MAZE LEARNING; MICROGLIA; NEURITIS; NEURONS; PROSENCEPHALON; RATS; RATS, INBRED F344; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032509740     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01215-8     Document Type: Article

References (58)

1. Aisen P.S., Davis K.L. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am. J. Psychiat. 151:1994;1105-1113.
2. Akiyama H., Toyama I., Kondo H., Ikeda K., Kimura H., McGeer E.G., McGeer P.L. Early response of brain resident microglia to kainic acid-induced hippocampal lesions. Brain Res. 635:1994;257-268.
3. Allen S.J., Dawbarn D., Wilcock G.K. Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease. Brain Res. 454:1988;275-281.
4. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia. 7:1993;111-118.
5. Bauer J., Strauss S., Schreiter-Gasser U., Schlegel P., Witt I., Yolk B., Berger M. Interleukin-6 and α2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285:1991;111-114.
6. Berger-Sweeney J., Heckers S., Mesulam M.-M., Wiley R.G., Lapp D.A., Sharma M. Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis. J. Neurosci. 14:1994;4507-4519.
7. Bhat R.V., DiRocco R., Marcy V.R., Flood D.G., Zhu Y., Dobrzanski P., Siman R., Scott R., Contreras P.C., Miller M. Increased expression of IL-1β converting enzyme in hippocampus after ischemia: selective localization in microglia. J. Neurosci. 16:1996;4146-4154.
8. Bigl V., Arendt T., Fischer S., Fischer S., Werner M., Arendt A. The cholinergic system in aging. Gerontology. 33:1987;172-180.
9. Bluthe R.-M., Dantzer R., Kelley K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res. 573:1992;318-320.
10. Breitner J.C., Gav B.A., Welsh K.A., Plassman B.L., McDonald W.M., Helms M.J. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 44:1994;227-232.
11. Brugg B., Dubreuil Y.L., Huber G., Wollman E.E., Delhaye-Bouchaud N., Mariani J. Inflammatory processes induce β-amyloid precursor protein changes in mouse brain. Proc. Natl. Acad. Sci. USA. 92:1995;3032-3035.
12. Colicos M.A., Dixon C.E., Dash P.K. Delayed, selective neuronal death following experimental cortical impact injury in rats: possible role in memory deficits. Brain Res. 739:1996;111-119.
13. Crutcher K.A., Scott S.A., Liang S., Everson W.V., Weingartner J. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J. Neurosci. 13:1993;2540-2550.
14. Eddleston M., Mucke L. Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience. 54:1993;15-36.
15. Fagan A.M., Suhr S.T., Lucidi-Phillipi C.A., Peterson D.A., Holtzman D.M., Gage F.H. Endogenous FGF-2 is important for cholinergic sprouting in the denervated hippocampus. J. Neurosci. 17:1997;2499-2511.
16. Fann M.-J., Patterson P.H. A novel approach to screen for cytokine effects on neuronal gene expression. J. Neurochem. 61:1993;1349-1355.
17. Finsen B.R., Jorgensen M.B., Zimmer J. Microglia MHC antigen expression after ischemic and kainic acid lesions of the adult rat hippocampus. Glia. 7:1993;41-49.
18. Flaris N.A., Densmore T.L., Molleston M.C., Hickey W.F. Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia. 7:1993;34-40.
19. Fonnum F. Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem. J. 115:1969;465-472.
20. Frederickson R.C.A., Brunden K.R. New opportunities in AD research - roles of immunoinflammatory responses and glia. Alz. Dis. Assoc. Dis. 8:1994;159-165.
21. Giulian D., Haverkamp L.J., Yu J.H., Karshin W., Tom D., Li J., Kirkpatrick J., Kuo Y.-M., Roher A.E. Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16:1996;6021-6027.
22. Goldgaber D., Harris H.W., Hla T., Maciag T., Donnelly R.J., Jacobsen J.S., Vitek M.P., Gajdusek D.C. Interleukin-1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelia cells. Proc. Natl. Acad. Sci. USA. 86:1989;7606-7610.
23. Goodman J.C., Cherian L., Bryan R.M. Jr., Robertson C.S. Lateral cortical impact injury in rats: pathological effects of varying cortical compression and impact velocity. J. Neurotrauma. 11:1994;587-597.
24. Griffin W.S.T., Sheng J.G., Gentleman S.M., Graham D.I., Mrak R.E., Roberts G.W. Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci. Lett. 176:1994;133-136.
25. Griffin W.S.T., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L., Arora C. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down Syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
26. Hanisch U.-K., Neuhaus J., Rowe W., Van Rossum D., Möller, Kettenmann H., Quirion R. Neurotoxic consequences of central long-term administration of interleukin-2 in rats. Neuroscience. 79:1997;799-818.
27. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:1992;184-185.
28. Hoffman F.M., Hinton D.R., Johnson K., Merrill J.E. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170:1989;607-612.
29. Hyman B.T., Van Hoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 225:1984;1168-1170.
30. Jarrard L.E. On the role of the hippocampus in learning and memory in the rat. Behav. Neural Biol. 60:1993;9-26.
31. Kannan Y., Bienenstock J., Ohta M., Stanisz A.M., Stead R.H. Nerve growth factor and cytokines mediate lymphoid tissue-induced neurite outgrowth from mouse superior cervical ganglia in vitro. J. Immunol. 156:1996;313-320.
32. Krueger J.M., Toth L.A. Cytokines as regulators of sleep. Ann. NY Acad. Sci. 739:1994;299-310.
33. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
34. Mann D.M.A. Pathological correlates of dementia in Alzheimer's disease. Neurobiol. Aging. 15:1994;357-360.
35. McDonald D., Brunden K., Landreth G. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17:1997;2284-2294.
36. McGeer P.L., Akiyama H., Itagaki S., McGeer E.G. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16:1989;516-527.
37. McGeer P.L., McGeer E.G., Suzuki J., Dolman C.E., Nagai T. Aging, Alzheimer's disease and the cholinergic system of the basal forebrain. Neurology. 34:1984;741-745.
38. Mrak R.E., Sheng J.G., Griffin W.S.T. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Human Pathol. 26:1995;816-823.
39. Morris R.G.M., Garrud P., Rawlins P., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 297:1982;681-683.
40. Olton D.S., Becker J.T., Handelmann G.E. Hippocampus, space and memory. Behav. Brain Sci. 2:1979;313-365.
41. D.S. Olton, G.L. Wenk, Dementia: animal models of the cognitive impairments produced by degeneration of the basal forebrain cholinergic system, in: H.Y. Meltzer (Ed.), Psychopharmacology: The Third Generation of Progress, Raven Press, New York, 1987, pp. 941-953.
42. Perry V.H., Matyszak M.K., Fearn S. Altered antigen expression of microglia in the aged rodent CNS. Glia. 7:1993;60-67.
43. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
44. Price J.L. Tangles and plaques in healthy aging and Alzheimer's disease: independence or interaction? Sem. Neurosci. 6:1994;395-402.
45. Quan N., Sundar S.K., Weiss J. Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J. Neuroimmunol. 49:1994;125-134.
46. Rasmusson D.X., Brandt J., Martin D.B., Folstein M.F. Head injury as a risk factor in Alzheimer's disease. Brain Inj. 9:1995;213-219.
47. Rinne J.O., Paljarvi L., Rinne K. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease. J. Neuronal Sci. 79:1987;67-76.
48. Rogers J., Cooper N., Webster S., Schultz J., McGeer P.L., Styren S.D., Civin W.H., Brachova L., Bradt B., Ward P., Lieberburg I. Complement activation by β-amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 89:1992;10016-10020.
49. Rogers J., Kirby L.C., Hempelman S.R., Berry D.L., McGeer P.L., Kaszniak A.W., Zalinski J., Cofield M., Mansukhani L., Wilson P., Kogan F. Clinical trials of indomethacin in Alzheimer's disease. Neurology. 43:1993;1609-1611.
50. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
51. Sheng J.G., Ito K., Skinner R.D., Mrak R.E., Rovnaghi C.R., Van Eldik L.J., Griffin S.T. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging. 17:1996;761-766.
52. Swaab D.F., Hofman M.A., Lucassen P.J., Salehi A., Uylings H.B.M. Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease. Neurobiol. Aging. 15:1994;369-371.
53. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
54. Vogels O.J.M., Broere C.A.J., Ter Laak H.J., Ten Donkelaar H.J., Nieuwenhys R., Schulte B.P.M. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol. Aging. 11:1990;3-13.
55. Wenk G.L., Harrington C.A., Walker L.C., Tucker D.A., Rance N.E. Basal forebrain neurons and memory: a biochemical, histological and behavioral study of differential vulnerability to ibotenate and quisqualate. Behav. Neurosci. 106:1992;909-923.
56. G.L. Wenk, D.S. Olton, Basal forebrain cholinergic neurons and Alzheimer's disease, in: J.T. Coyle (Ed.), Animal Models of Dementia: A Synaptic Neurochemical Perspective, Neurology and Neurobiology, Vol. 33, Alan R. Liss, New York, 1987, pp. 81-101.
57. Wenk G.L., Stoehr J.D., Quintana G., Mobley S.L., Wiley R.G. Behavioral, biochemical, histological and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J. Neurosci. 14:1994;5986-5995.
58. P.J. Whitehouse, R.G. Struble, J.C. Hedreen, A.W. Clark, D.L. Price, Alzheimer's disease and related dementias: Selective involvement of specific neuronal systems, in: J.C. Blass (Ed.), Critical Reviews in Clinical Neurobiology, CRC Press, New York, 1985, pp. 319-339.